GlassScriptPhysician profile
Matthew Carnevale
NPI 1831650332
$525.28
in general payments reported to CMS, 2019-2025
8 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $272 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $229.39 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Endologix LLC | $137.31 | 2025 | Endocross Device, Torus Stent Graft System |
| Boston Scientific Corporation | $38.06 | 2024-2025 | Eluvia |
| Getinge USA Sales, LLC | $30.63 | 2025 | Flixene |
| Humacyte Global, INC. | $27.30 | 2025 | Symvess |
| Terumo Medical Corporation | $24.22 | 2024 | Navicross, Metacross Otw, Glidesheath Slender |
| Smith+Nephew, INC. | $21.76 | 2024 | Collagenase Santyl |
| Hydrofera LLC | $16.61 | 2024 | Hydrofera Blue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Carnevale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.